Genprex Inc
For the period ended Dec 31, 2023. Filed Apr 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 1, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
Rule10b5*-1 Trading Arrangements and Non-Rule10b5-1 Trading Arrangements*
During the fiscal quarter ended* December 31, 2023,none of our officers or directors, as those terms are defined in Rule16a*-1(f), adopted or terminated a “Rule10b5-1 trading arrangement” or a “non-Rule10b5-1 trading arrangement,” as those terms are defined in Item408 of Regulation S-K.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.